X-linked lysosomal storage disorder.
  Lysosomal enzyme alpha-galactosidase A degrades glycosphingolipids.
  Deficient alpha-galactosidase activity leads to the deposition of globotriaosylceramide in cells and tissues.
  Morphologically, cardiac involvement mimics hypertrophic cardiomyopathy.
  ECG abnormalities in Fabry disease are frequent but nonspecific.
  ECG signs of left ventricular hypertrophy (20-60%)
  Short PR interval without delta wave (20-40%) (due to accelerated atrioventricular conduction; not due to accessory pathway).
  Negative T waves (common).
  Intraventricular conduction block (QRS widening)
  Paroxysmal atrial fibrillation.
  Various types of atrioventricular (AV) blocks (more common in terminal stage cardiac Fabry disease)
  ECG findings suggestive of sick sinus syndrome (more common in terminal stage cardiac Fabry disease)
  Ventricular arrhythmias (more common in terminal stage cardiac Fabry disease)
  Tex Heart Inst J 2016;43(6):531-533.
  Clin Cardiol 2018 Jun 30. doi: 10.1002/clc.23019.
  JIMD Rep 2015;28:19-28.
  Heart 2011;97(6):485-490.
  Heart 2010;96(21):1782-1783.
  Am J Cardiol 2010;106:1492-1499
  Arch Intern Med 2009;169(20):1925-1926
  Pacing Clin Electrophysiol 2008;31(6):782-783
  Europace 2006;8:1045-1047
  Heart 2006;92:685
  N Engl J Med 2005;352:362-372
  N Engl J Med 2003;348:1186-1187
  Circulation 2007;116:e350-351
  Br Heart J 1992;68:323-325
  Br Heart J 1987;57:296-299
  Postgrad Med J 1986;62:285-287
  Angiology 1978;29(7):562-568
  J Am Coll Cardiol 2009;55:1769-1779.
  Journal of Cardiology 2008;51:50-59
  Am J Cardiol 2005;96:842-846.
  Eur J Pediatr 2003;162:767-72.
  Acta Paediatr Suppl 2002;91:15-20.

